Literature DB >> 10989777

Ultra rapid opiate detoxification as compared to 30-day inpatient detoxification program--a retrospective follow-up study.

E Lawental1.   

Abstract

PURPOSE: Ultra rapid detoxification (URD) has recently gained significant media attention as a promising treatment for opiate addiction. URD combined with follow-up naltrexone was portrayed as a quick and painless initial detoxification, as well as a long-term cure for the addiction. Following the therapeutic initiation of URD, articles began to emerge in the scientific literature. URD was skeptically viewed by the substance addiction treatment community, skepticism initially based on the theoretical understanding of addiction as a bio-psycho-social problem and the belief that detoxification and medication alone cannot provide long-term abstinence. This initial response was later supported by some scientific studies. URD continues to stir controversy, leading to this study.
METHODS: We used available data to conduct a pilot study of URD, comparing it to traditional 30-day inpatient detoxification programs (IDP) used in Israel in achieving long-term abstinence. A sample of 226 men and women, 18 years or older, who entered detoxification in the IDP (N = 87) or in the URD (N = 139) were all clients who received treatment in either of these programs between March and September 1996. Eighty-one (92%) of the IDP subjects and eighty-two (60%) of the URD subjects were successfully interviewed by telephone 12 to 18 months after their participation in these programs.
RESULTS: The results provide preliminary evidence that URD may be much less effective and more expensive than traditional treatment. No specific subgroup of clients benefited more from URD, although a prospective study employing random assignment might be more successful in identifying such a group. IMPLICATIONS: This study appears to offer justification for the current longer-term bio-psycho-social treatment alternatives for opiate addiction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10989777     DOI: 10.1016/s0899-3289(00)00019-5

Source DB:  PubMed          Journal:  J Subst Abuse        ISSN: 0899-3289


  6 in total

Review 1.  Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.

Authors:  Linda Gowing; Robert Ali; Jason M White
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 2.  Potential uses of naltrexone in emergency department patients with opioid use disorder.

Authors:  Evan Stuart Bradley; David Liss; Stephanie Pepper Carreiro; David Eric Brush; Kavita Babu
Journal:  Clin Toxicol (Phila)       Date:  2019-03-04       Impact factor: 4.467

Review 3.  Opioid dependence treatment: options in pharmacotherapy.

Authors:  Angela L Stotts; Carrie L Dodrill; Thomas R Kosten
Journal:  Expert Opin Pharmacother       Date:  2009-08       Impact factor: 3.889

Review 4.  Treatment of heroin (diamorphine) addiction: current approaches and future prospects.

Authors:  Gerardo Gonzalez; Alison Oliveto; Thomas R Kosten
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Six-month follow-up study of ultrarapid opiate detoxification with naltrexone.

Authors:  Mohammad Forozeshfard; Babak Hosseinzadeh Zoroufchi; Mohammad Bagher Saberi Zafarghandi; Razieh Bandari; Behzad Foroutan
Journal:  Int J High Risk Behav Addict       Date:  2014-09-17

6.  Ultrarapid opioid detoxification: current status in iran and controversies.

Authors:  Seyyed Mojtaba Yassini Ardekani; Sara Yassini Ardekani
Journal:  Int J High Risk Behav Addict       Date:  2013-12-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.